These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29061479)

  • 21. Toll-like receptor-9 signaling and decreased efficacy of antimalarial drugs in smokers with cutaneous lupus erythematosus.
    Kwatra SG
    J Am Acad Dermatol; 2015 Aug; 73(2):e79. PubMed ID: 26184008
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of smoking in cutaneous lupus erythematosus.
    Piette EW; Foering KP; Chang AY; Okawa J; Ten Have TR; Feng R; Werth VP
    Arch Dermatol; 2012 Mar; 148(3):317-22. PubMed ID: 22105815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    Pakchotanon R; Gladman DD; Su J; Urowitz MB
    J Rheumatol; 2018 Jan; 45(1):90-94. PubMed ID: 29142038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous Adverse Drug Reactions with Antimalarials and Allergological Skin Tests.
    Soria A; Barbaud A; Assier H; Avenel-Audran M; Tétart F; Raison-Peyron N; Amarger S; Girardin P; Francès C;
    Dermatology; 2015; 231(4):353-9. PubMed ID: 26457932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database.
    Kuhn A; Sigges J; Biazar C; Ruland V; Patsinakidis N; Landmann A; Amler S; Bonsmann G;
    Br J Dermatol; 2014 Sep; 171(3):571-9. PubMed ID: 24673427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival.
    Sisó A; Ramos-Casals M; Bové A; Brito-Zerón P; Soria N; Muñoz S; Testi A; Plaza J; Sentís J; Coca A
    Lupus; 2008 Apr; 17(4):281-8. PubMed ID: 18413408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice Gaps. Optimizing antimalarial therapy for cutaneous lupus erythematosus: comment on "Response to antimalarial agents in cutaneous lupus erythematosus".
    Callen JP
    Arch Dermatol; 2011 Nov; 147(11):1267-8. PubMed ID: 22106112
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.
    Gammon B; Hansen C; Costner MI
    J Am Acad Dermatol; 2011 Oct; 65(4):717-721.e2. PubMed ID: 21641078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mepacrine in Recalcitrant Cutaneous Lupus Erythematosus: Old-fashioned or Still Useful?
    Benoit S; Goebeler M
    Acta Derm Venereol; 2015 May; 95(5):596-9. PubMed ID: 25474442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.
    Ototake Y; Yamaguchi Y; Kanaoka M; Akita A; Ikeda N; Aihara M
    J Dermatol; 2019 Apr; 46(4):285-289. PubMed ID: 30719729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
    Spinelli FR; Moscarelli E; Ceccarelli F; Miranda F; Perricone C; Truglia S; Garufi C; Massaro L; Morello F; Alessandri C; Valesini G; Conti F
    Lupus; 2018 Sep; 27(10):1616-1623. PubMed ID: 29954281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effectiveness of antimalarial drugs in rheumatic diseases.
    Aviña-Zubieta JA; Galindo-Rodriguez G; Newman S; Suarez-Almazor ME; Russell AS
    Ann Rheum Dis; 1998 Oct; 57(10):582-7. PubMed ID: 9893568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series].
    González-Sixto B; García-Doval I; Oliveira R; Posada C; García-Cruz MA; Cruces M
    Actas Dermosifiliogr; 2010; 101(1):54-8. PubMed ID: 20109393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidimensional Immune Profiling of Cutaneous Lupus Erythematosus In Vivo Stratified by Patient Response to Antimalarials.
    Patel J; Vazquez T; Chin F; Keyes E; Yan D; Diaz D; Grinnell M; Sharma M; Li Y; Feng R; Sprow G; Dan J; Werth VP
    Arthritis Rheumatol; 2022 Oct; 74(10):1687-1698. PubMed ID: 35583812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.
    Momose Y; Arai S; Eto H; Kishimoto M; Okada M
    J Dermatol; 2013 Feb; 40(2):94-7. PubMed ID: 23216212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term use of antimalarial drugs in rheumatic diseases.
    Jover JA; Leon L; Pato E; Loza E; Rosales Z; Matias MA; Mendez-Fernandez R; Díaz-Valle D; Benitez-Del-Castillo JM; Abasolo L
    Clin Exp Rheumatol; 2012; 30(3):380-7. PubMed ID: 22339928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking enhances Toll-like receptor-9 responsiveness and type I interferon production in plasmacytoid dendritic cells in patients with cutaneous lupus erythematosus.
    Chasset F; Francès C; Arnaud L
    J Am Acad Dermatol; 2015 Aug; 73(2):e81. PubMed ID: 26184009
    [No Abstract]   [Full Text] [Related]  

  • 39. Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus.
    Al-Rawi H; Meggitt SJ; Williams FM; Wahie S
    Lupus; 2018 Apr; 27(5):847-852. PubMed ID: 28862574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study.
    Cesbron E; Bessis D; Jachiet M; Lipsker D; Cordel N; Bouaziz JD; Bagot M; Arnaud L; Barbaud A; Francès C; Chasset F;
    J Am Acad Dermatol; 2018 Jul; 79(1):162-165. PubMed ID: 29496481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.